The company is the second vaccine maker to seek full approval from U.S. regulators.
Related posts:
China admits its vaccines aren’t very good
China hasn’t been forthright on Covid, Blinken says
Desperate for treatment, Covid ‘long haulers’ push for 9/11-style health registry
Attacks on Fauci grow more intense, personal and conspiratorial
Virus lab leak theory dogs Democrats eager to keep focus on Trump’s Covid failings
Skeptics question if Biden’s new science agency is a breakthrough or more bureaucracy
Government leaders to their workers: Get vaccinated or get tested
Confusion over Covid-19 boosters lingers as states roll out shots
Biden officials split on Covid-19 boosters as they plot course for winter
Merck’s promising experimental Covid-19 drug raises hopes for pill to fight virus
U.S. to defer 33M Covid vaccine doses to Africa
Dems’ drug pricing dreams crash into reality in social spending tumult
